NO2920199T3 - - Google Patents

Info

Publication number
NO2920199T3
NO2920199T3 NO14832966A NO14832966A NO2920199T3 NO 2920199 T3 NO2920199 T3 NO 2920199T3 NO 14832966 A NO14832966 A NO 14832966A NO 14832966 A NO14832966 A NO 14832966A NO 2920199 T3 NO2920199 T3 NO 2920199T3
Authority
NO
Norway
Application number
NO14832966A
Other languages
Norwegian (no)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=49987856&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO2920199(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed filed Critical
Publication of NO2920199T3 publication Critical patent/NO2920199T3/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/52Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/33Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Clostridium (G)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/16Extraction; Separation; Purification by chromatography
    • C07K1/18Ion-exchange chromatography
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/30Extraction; Separation; Purification by precipitation
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/36Extraction; Separation; Purification by a combination of two or more processes of different types
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y304/00Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/24Metalloendopeptidases (3.4.24)
    • C12Y304/24069Bontoxilysin (3.4.24.69), i.e. botulinum neurotoxin

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Analytical Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
NO14832966A 2013-08-02 2014-05-07 NO2920199T3 (en:Method)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020130092024A KR101339349B1 (ko) 2013-08-02 2013-08-02 보툴리눔 독소의 제조방법
PCT/KR2014/004003 WO2015016462A1 (en) 2013-08-02 2014-05-07 Method for production of botulinum toxin

Publications (1)

Publication Number Publication Date
NO2920199T3 true NO2920199T3 (en:Method) 2018-08-04

Family

ID=49987856

Family Applications (1)

Application Number Title Priority Date Filing Date
NO14832966A NO2920199T3 (en:Method) 2013-08-02 2014-05-07

Country Status (25)

Country Link
US (1) US9512418B2 (en:Method)
EP (1) EP2920199B1 (en:Method)
JP (2) JP6307150B2 (en:Method)
KR (1) KR101339349B1 (en:Method)
CN (1) CN105392795B (en:Method)
AR (1) AR096541A1 (en:Method)
AU (1) AU2014297167B2 (en:Method)
BR (1) BR112015029973B1 (en:Method)
CA (1) CA2912553C (en:Method)
CY (1) CY1120410T1 (en:Method)
DK (1) DK2920199T3 (en:Method)
ES (1) ES2665288T3 (en:Method)
HR (1) HRP20180679T1 (en:Method)
HU (1) HUE036840T2 (en:Method)
LT (1) LT2920199T (en:Method)
MX (1) MX362821B (en:Method)
NO (1) NO2920199T3 (en:Method)
PH (1) PH12015501855A1 (en:Method)
PL (1) PL2920199T3 (en:Method)
PT (1) PT2920199T (en:Method)
RU (1) RU2627159C2 (en:Method)
SA (1) SA515370208B1 (en:Method)
SG (1) SG11201509486VA (en:Method)
SI (1) SI2920199T1 (en:Method)
WO (1) WO2015016462A1 (en:Method)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8129139B2 (en) 2009-07-13 2012-03-06 Allergan, Inc. Process for obtaining botulinum neurotoxin
KR101339349B1 (ko) * 2013-08-02 2013-12-09 주식회사 대웅 보툴리눔 독소의 제조방법
KR101723167B1 (ko) 2015-04-28 2017-04-05 주식회사 대웅 보툴리눔 독소의 제조를 위한 배지 조성물
KR101729251B1 (ko) 2015-04-28 2017-04-21 주식회사 대웅 보툴리눔 독소의 제조를 위한 배지 조성물
KR101723168B1 (ko) 2015-04-28 2017-04-05 주식회사 대웅 보툴리눔 독소의 제조를 위한 배지 조성물
KR101853463B1 (ko) * 2015-09-09 2018-06-20 휴젤(주) 보툴리눔 독소의 정제 방법
KR101775682B1 (ko) 2015-11-30 2017-09-06 주식회사 대웅 보툴리눔 독소의 제조방법
CN109641941B (zh) * 2016-05-16 2023-06-16 哈佛大学校长及研究员协会 用于纯化和激活肉毒杆菌神经毒素的方法
KR102463881B1 (ko) 2016-10-04 2022-11-07 (주)메디톡스 보툴리눔 독소 함유 용액으로부터 보툴리눔 독소를 분리하는 방법
KR101744900B1 (ko) 2017-01-20 2017-06-08 주식회사 대웅 보툴리눔 독소를 포함하는 안정한 액상 조성물
CN109646673A (zh) * 2017-10-12 2019-04-19 秀杰股份公司 肉毒杆菌毒素的微结构制剂技术
CA3124535A1 (en) 2018-12-21 2020-06-25 The Research Foundation For Microbial Diseases Of Osaka University Botulinum toxin producing method
KR102516204B1 (ko) * 2019-04-15 2023-03-30 (주)제테마 보툴리눔 독소의 정제방법
KR102516203B1 (ko) * 2019-04-15 2023-03-30 (주)제테마 보툴리눔 독소의 제조방법
TWI854077B (zh) * 2019-12-20 2024-09-01 瑞士商葛德瑪控股公司 生產肉毒桿菌毒素的方法
TW202136286A (zh) * 2019-12-20 2021-10-01 瑞士商葛德瑪控股公司 純化肉毒桿菌毒素的方法
KR102724651B1 (ko) * 2021-07-08 2024-11-01 주식회사 파마리서치바이오 비-독소 단백질이 제거된 클로스트리디움 보툴리눔 신경독소 단백질의 정제방법
TWI852454B (zh) * 2022-04-01 2024-08-11 大陸商重慶譽顏製藥有限公司 一種肉毒毒素蛋白組合物、製備方法及其應用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20030060150A (ko) * 2002-01-07 2003-07-16 (주)메디톡스 클로스트리디움 보툴리눔 a형 독소를 정제하는 방법
RU2206337C1 (ru) * 2002-10-29 2003-06-20 Общество с ограниченной ответственностью "Токсины и сопутствующие продукты" Лекарственный препарат для лечения мышечных дистоний и способ его получения
US7452697B2 (en) * 2003-09-25 2008-11-18 Allergan, Inc. Chromatographic method and system for purifying a botulinum toxin
US7879341B2 (en) * 2004-07-26 2011-02-01 Merz Pharma Gmbh & Co. Kgaa Therapeutic composition with a botulinum neurotoxin
AU2005327458B2 (en) * 2005-03-03 2011-12-15 Allergan, Inc. Animal product free system and process for purifying a botulinum toxin
KR101025617B1 (ko) * 2008-02-25 2011-03-30 메덱스젠 주식회사 클로스트리디움 보툴리눔으로부터 보툴리눔 독소를정제하는 방법
US8129139B2 (en) * 2009-07-13 2012-03-06 Allergan, Inc. Process for obtaining botulinum neurotoxin
HRP20181869T1 (hr) * 2009-10-21 2019-01-11 Revance Therapeutics, Inc. Metode i sustavi za pročišćavanje nekompleksiranog botulinskog neurotoksina
KR101434558B1 (ko) * 2011-07-21 2014-08-27 (주)메디톡스 식물 유래 성분 함유 배지 및 가요성 폐쇄 용기를 이용하여 클로스트리디움 보툴리눔 독소를 생산하는 방법
KR101339349B1 (ko) * 2013-08-02 2013-12-09 주식회사 대웅 보툴리눔 독소의 제조방법

Also Published As

Publication number Publication date
US20150337281A1 (en) 2015-11-26
ES2665288T3 (es) 2018-04-25
CN105392795A (zh) 2016-03-09
PL2920199T3 (pl) 2018-08-31
EP2920199B1 (en) 2018-03-07
KR101339349B1 (ko) 2013-12-09
JP2017141237A (ja) 2017-08-17
MX362821B (es) 2019-02-18
RU2015151186A (ru) 2017-06-01
PT2920199T (pt) 2018-05-30
HUE036840T2 (hu) 2018-08-28
WO2015016462A1 (en) 2015-02-05
HRP20180679T1 (hr) 2018-06-01
SI2920199T1 (en) 2018-06-29
CN105392795B (zh) 2019-11-22
CA2912553A1 (en) 2015-02-05
AU2014297167A1 (en) 2015-12-10
BR112015029973A2 (pt) 2017-07-25
BR112015029973B1 (pt) 2023-01-17
CY1120410T1 (el) 2019-07-10
AU2014297167B2 (en) 2016-11-17
RU2627159C2 (ru) 2017-08-03
JP6307150B2 (ja) 2018-04-04
SA515370208B1 (ar) 2017-07-08
LT2920199T (lt) 2018-04-10
US9512418B2 (en) 2016-12-06
HK1215715A1 (zh) 2016-09-09
EP2920199A1 (en) 2015-09-23
PH12015501855B1 (en) 2015-12-07
PH12015501855A1 (en) 2015-12-07
CA2912553C (en) 2018-01-02
JP2016521968A (ja) 2016-07-28
DK2920199T3 (en) 2018-05-28
AR096541A1 (es) 2016-01-13
MX2015016481A (es) 2016-06-10
SG11201509486VA (en) 2015-12-30
EP2920199A4 (en) 2016-10-05

Similar Documents

Publication Publication Date Title
AP2016009275A0 (en:Method)
BR112015007533A2 (en:Method)
BR102016010778A2 (en:Method)
BR112014018502A2 (en:Method)
BR112014019326A2 (en:Method)
BR112016000667A2 (en:Method)
BR112014018516A2 (en:Method)
BR112014018480A2 (en:Method)
BR112014020341A2 (en:Method)
BR112014021878A2 (en:Method)
BR112016008943A2 (en:Method)
BR112016009209A2 (en:Method)
NO2920199T3 (en:Method)
BR112014018468A2 (en:Method)
BR112014019204A2 (en:Method)
BR112014017901A2 (en:Method)
BR112014018207A2 (en:Method)
BR112015015948A2 (en:Method)
BR112014018578A2 (en:Method)
BR112014018483A2 (en:Method)
BR112014017601A2 (en:Method)
BR112015015312A2 (en:Method)
BR112014024039A2 (en:Method)
BR112014018353A2 (en:Method)
BR112014018496A2 (en:Method)